DSGN
Price
$5.95
Change
-$0.30 (-4.80%)
Updated
Dec 18, 04:59 PM (EDT)
77 days until earnings call
POLBF
Price
$0.12
Change
-$0.03 (-20.00%)
Updated
Nov 7 closing price
Ad is loading...

DSGN vs POLBF

Header iconDSGN vs POLBF Comparison
Open Charts DSGN vs POLBFBanner chart's image
Design Therapeutics
Price$5.95
Change-$0.30 (-4.80%)
Volume$1.04K
CapitalizationN/A
Poolbeg Pharma
Price$0.12
Change-$0.03 (-20.00%)
Volume$300
CapitalizationN/A
DSGN vs POLBF Comparison Chart
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
POLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. POLBF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and POLBF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (DSGN: $5.95 vs. POLBF: $0.12)
Brand notoriety: DSGN and POLBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 157% vs. POLBF: 100%
Market capitalization -- DSGN: $353.88M vs. POLBF: $46.64M
DSGN [@Biotechnology] is valued at $353.88M. POLBF’s [@Biotechnology] market capitalization is $46.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whilePOLBF’s FA Score has 0 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • POLBF’s FA Score: 0 green, 5 red.
According to our system of comparison, POLBF is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 3 TA indicator(s) are bullish while POLBF’s TA Score has 2 bullish TA indicator(s).

  • DSGN’s TA Score: 3 bullish, 6 bearish.
  • POLBF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, POLBF is a better buy in the short-term than DSGN.

Price Growth

DSGN (@Biotechnology) experienced а -13.77% price change this week, while POLBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.11%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was +0.25%.

Reported Earning Dates

DSGN is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($354M) has a higher market cap than POLBF($46.6M). DSGN YTD gains are higher at: 135.849 vs. POLBF (2.609).
DSGNPOLBFDSGN / POLBF
Capitalization354M46.6M760%
EBITDA-60.23MN/A-
Gain YTD135.8492.6095,208%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash254MN/A-
Total Debt2.52MN/A-
TECHNICAL ANALYSIS
Technical Analysis
DSGNPOLBF
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
25%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
17%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
12%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
12%
Advances
ODDS (%)
Bullish Trend 8 days ago
88%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
77%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
9%
View a ticker or compare two or three
Ad is loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
POLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DBMF27.150.01
+0.04%
iMGP DBi Managed Futures Strategy ETF
APRH25.03N/A
N/A
Innovator Premium Income 20 Bar ETF -Apr
GOOY15.74N/A
N/A
YieldMax GOOGL Option Income Stgy ETF
VNQ93.07-0.45
-0.48%
Vanguard Real Estate ETF
NETZ74.52-1.18
-1.56%
TCW Transform Systems ETF

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with CYTK. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-0.64%
CYTK - DSGN
39%
Loosely correlated
-2.53%
MDGL - DSGN
38%
Loosely correlated
-1.58%
AGIO - DSGN
36%
Loosely correlated
-1.71%
VRDN - DSGN
35%
Loosely correlated
-3.34%
RCKT - DSGN
35%
Loosely correlated
+1.36%
More

POLBF and

Correlation & Price change

A.I.dvisor tells us that POLBF and NNVC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POLBF and NNVC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POLBF
1D Price
Change %
POLBF100%
N/A
NNVC - POLBF
26%
Poorly correlated
+0.67%
BOLT - POLBF
26%
Poorly correlated
-5.89%
BEIGF - POLBF
25%
Poorly correlated
N/A
DSGN - POLBF
25%
Poorly correlated
-4.80%
ALXO - POLBF
22%
Poorly correlated
+2.79%
More